Phosphorex Exhibits at ASGCT 2026

Phosphorex exhibited in the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, engaging with innovators and industry leaders across the cell and gene therapy community.

Representing Phosphorex at the event were:

• Jerry Williamson – Chief Executive Officer
• Evan Turek – Senior Director, Business Development
• Aditya (Adi) Kulkarni – Business Development Director

Throughout the meeting, the team connected with attendees on topics spanning advanced drug delivery, lipid nanoparticle (LNP) development, polymeric particle systems, formulation optimization, analytical characterization, and scalable process development for next-generation therapeutics.

ASGCT continues to serve as an important forum for scientific exchange and collaboration across the rapidly evolving cell and gene therapy landscape. Participation in the event reflects Phosphorex’s ongoing commitment to supporting innovators developing complex therapeutics through integrated formulation, process, analytical, and delivery expertise.

For those who were unable to connect with the team during the event, Phosphorex welcomes the opportunity to continue the conversation and discuss how its drug delivery expertise can support future programs.